A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

NCT02601287 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Incontinence
Overactive Bladder

Interventions

BIOLOGICAL: Botulinum Toxin Type A

Sponsor

Allergan